|
CNTR has partnered with Aroa Biosurgery to launch the COVER Study (Combined OFM and Vacuum-assisted therapy for Expedited Regeneration over Structures), a randomized controlled trial investigating whether combining Ovine Forestomach Matrix with negative pressure wound therapy can speed soft tissue coverage of exposed bone and tendon injuries.
Led by study PI LTC Julie Rizzo, MD, the study has received institutional review board approval and begins enrollment this month at UT Health San Antonio and the University of Colorado Anschutz, the study builds on promising multicenter data and aims to validate a faster, cost-effective treatment pathway for trauma and acute care surgery teams.
The COVER study aims to add evidence to validate a treatment algorithm for achieving rapid coverage of soft tissue defects presenting to trauma/acute care surgery teams in a cost-effective manner, increasing patient satisfaction and hospital efficiency.
|